E-Scape Bio is a biopharmaceutical company focused on the discovery and development of small-molecule drugs to treat genetically-defined subpopulations in neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. The company's therapeutic programs are designed to restore normal function disrupted by inherited genetic mutations causing the disease.

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
07/12/17	$63,000,000	Series A Extension	Johnson & Johnson Development Corporation (JJDC) Lilly Asia Ventures Novartis Venture Funds Novo A/S OrbiMed Advisors Osage University Partners Sutter Hill Ventures	undisclosed